TransMedics Group, Inc..
TMDX.US | Manufacture of medical and dental instruments and supplies
TransMedics Group, Inc. is a medical technology company transforming organ transplant therapy for end-stage organ failure patients. They have developed the Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. The OCS technology is designed to preserve organs in a...Show More
Better Health for All
-30
TransMedics' core product, the Organ Care System (OCS), delivers revolutionary health benefits by preserving hearts for transplantation, including donation-after-brain-death (DBD) and donation-after-circulatory-death (DCD) hearts, expanding access to life-saving therapy.
1
The OCS system achieved a 94.9% utilization rate for instrumented hearts in a study.
2
However, the safety record indicates notable safety incidents, with the user manual disclosing lower survival rates in some studies using the OCS Heart System compared to cold static preservation for DBD hearts, and potential for myocardial injury in some DBD hearts.
3
The company demonstrates excellent risk transparency by disclosing these potential risks and benefits in its user manual.
4
TransMedics provides training programs for qualified healthcare professionals and user training programs.
5
Data from preservation sessions are logged and stored on TransMedics-approved data cards.
6
Clinical trial descriptions are included in appendices of the user guide,
7
and FDA approval for the OCS DCD Heart indication was based on trial results and a Continued Access Protocol.
8
Fair Money & Economic Opportunity
0
TransMedics Group, Inc. is a medical technology company focused on organ transplant therapy.
1
Its core business does not involve lending, insuring, moving, or storing money for consumers, nor does it offer financial services or products.
2
Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcome, profit reinvestment, financial literacy initiatives, debt burden ratio, geographic inclusion, and product simplicity, are not applicable to the company's operations.
3
The company does not generate or manage customer finance data, nor does it offer consumer credit products or financial education programs.
4
Fair Pay & Worker Respect
20
TransMedics Group, Inc. reported a CEO to median employee pay ratio of 58:1 for the 2024 fiscal year, with the CEO's total compensation at $8,199,136 and median employee pay at $141,564.
1
The company offers comprehensive health and welfare plans, including medical, dental, vision, life, and disability insurance, to all full-time U.S. employees, including named executive officers.
2
This coverage extends to approximately 100% of employees, including dependents and mental health services. No regulatory actions, violations, fines, or compliance issues are mentioned in the provided articles. Employee engagement, based on an overall rating of 3.1 out of 5 stars (62/100) from 26 reviews for its Andover location, indicates growing trust.
3
Fair Trade & Ethical Sourcing
0
No evidence available to assess TransMedics Group, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete data points were found in the provided articles for any of the KPIs related to Honest & Fair Business. The articles primarily discuss allegations of securities law violations, including claims of kickbacks, fraudulent overbilling, coercive tactics, and unsafe practices, as well as a short-seller report alleging fraud and unethical practices.
1
TransMedics has denied all allegations.
2
However, these are allegations and lawsuits, not confirmed regulatory fines, specific policy details, or quantitative metrics that can be mapped to the scoring rubric. Therefore, all KPIs are omitted due to a lack of verifiable evidence.
Kind to Animals
0
No specific, concrete data points were found in the provided articles to assess TransMedics Group, Inc. against any of the 'Kind to Animals' KPIs. The articles explicitly state 'No Data' or 'No explicit mention' for all relevant animal welfare metrics, including cruelty-free certifications, alternative testing usage, humane certifications, wildlife conservation impact, ethical input substitution, supplier audits, cage-free sourcing, animal testing policy or volume, animal agriculture ethics, animal-free R&D collaboration, and public policy engagement related to animal welfare.
1
Although R&D expenses were reported, there was no breakdown indicating investment specifically in animal-free technologies or alternatives, which is required for the 'innovation_investment_pct' KPI.
2
No War, No Weapons
-70
The company conducted a due diligence process to review its worldwide supply chain for 3TG minerals, identifying 74 potentially in-scope suppliers.
1
Responses from these suppliers represented 90% of components that may contain 3TG, but the company was unable to determine with certainty the country of origin of the 3TG in its products.
2
This reasonable country of origin inquiry (RCOI) is based on the OECD Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas.
3
A cross-functional team met periodically to review and assess due diligence efforts and provide updates to senior management on a case-by-case basis.
4
Planet-Friendly Business
0
No evidence available to assess TransMedics Group, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No evidence available to assess TransMedics Group, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
-60
TransMedics' privacy policy indicates that users can opt-out of future mailings via email or website, representing a basic level of user data control.
1
The policy also mentions compliance with the EU General Data Protection Regulation (GDPR), but no further details on the depth or effectiveness of this compliance are provided.
2
Additionally, the policy states that personally identifiable information will not be collected without explicit permission when using cookies, suggesting a basic consideration for privacy in design, limited to website data collection.
3
Zero Waste & Sustainable Products
0
No specific, concrete data points were provided across the articles to assess TransMedics Group, Inc. against the 'Zero Waste & Sustainable Products' ethical value. While the company states it is evaluating products with the goal of optimizing and reducing environmental impacts across product lifecycles, this is a general goal and not evidence of implemented circular design principles or product recyclability.
1
The articles mention the company handles hazardous chemicals and biohazardous materials in its research and development programs, but no information is provided regarding the proper handling, minimization, or management practices for these materials.
2
There is no data on waste diversion rates, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, product durability, repairability, waste audit frequency, zero-waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
3